Arrowhead Pharmaceuticals Stock Options

ARWR Stock  USD 14.73  0.77  4.97%   
Arrowhead Pharmaceuticals' latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.82 with a put-to-call open interest ratio of 0.69 over 39 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on June 20th 2025. The total put volume is at 1.0, with calls trading at the volume of 25.0. This yields a 0.04 put-to-call volume ratio.

Open Interest Against June 20th 2025 Option Contracts

The chart above shows Arrowhead Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Arrowhead Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Arrowhead Pharmaceuticals' option, there is no secondary market available for investors to trade.

Arrowhead Pharmaceuticals Maximum Pain Price Across 2025-06-20 Option Contracts

Max pain occurs when Arrowhead Pharmaceuticals' market makers reach a net positive position across all Arrowhead Pharmaceuticals' options at a strike price where option holders stand to lose the most money. By contrast, Arrowhead Pharmaceuticals' option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Arrowhead Pharmaceuticals

Analyzing Arrowhead Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Arrowhead Pharmaceuticals regardless of its overall volatility. This is especially true when Arrowhead Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Arrowhead Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Arrowhead Pharmaceuticals' stock while costing only a fraction of its price.

Arrowhead Pharmaceuticals In The Money Call Balance

When Arrowhead Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Arrowhead Pharmaceuticals stock is said to be in the money. When it comes to buying Arrowhead Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Arrowhead Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Arrowhead Current Options Market Mood

Arrowhead Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Arrowhead Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Arrowhead Pharmaceuticals' options investors are not very successful. Arrowhead Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Arrowhead contract

Base on the Rule 16, the options market is currently suggesting that Arrowhead Pharmaceuticals will have an average daily up or down price movement of about 0.0513% per day over the life of the 2025-06-20 option contract. With Arrowhead Pharmaceuticals trading at USD 14.73, that is roughly USD 0.007549. If you think that the market is fully incorporating Arrowhead Pharmaceuticals' daily price movement you should consider buying Arrowhead Pharmaceuticals options at the current volatility level of 0.82%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Arrowhead Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Arrowhead calls. Remember, the seller must deliver Arrowhead Pharmaceuticals stock to the call owner when a call is exercised.

Arrowhead Pharmaceuticals Option Chain

When Arrowhead Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Arrowhead Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Arrowhead Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Arrowhead. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Arrowhead. It also shows strike prices and maturity days for a Arrowhead Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
ARWR250620C0003500023935.00.0 - 1.50.2Out
Call
ARWR250620C0003000037630.00.0 - 0.40.2Out
Call
ARWR250620C000280007328.00.0 - 1.750.23Out
Call
ARWR250620C000270005027.00.0 - 2.00.48Out
Call
ARWR250620C000260001626.00.05 - 1.01.85Out
Call
ARWR250620C0002500093725.00.0 - 0.950.2Out
Call
ARWR250620C0002400011024.00.0 - 1.050.25Out
Call
ARWR250620C0002300033423.00.0 - 1.10.45Out
Call
ARWR250620C0002200011922.00.0 - 1.20.46Out
Call
ARWR250620C000210005821.00.0 - 1.250.35Out
Call
ARWR250620C0002000055320.00.0 - 1.10.5Out
Call
ARWR250620C000190007719.00.15 - 0.950.5Out
Call
ARWR250620C000180009418.00.0 - 0.80.85Out
Call
ARWR250620C0001700015117.00.8 - 1.00.9Out
Call
ARWR250620C0001600013916.01.1 - 1.71.85Out
Call
ARWR250620C00015000515.01.5 - 1.71.6Out
Call
ARWR250620C000140004814.02.05 - 2.22.6In
Call
ARWR250620C000130008413.01.85 - 3.62.85In
Call
ARWR250620C00012000112.02.35 - 4.59.75In
Call
ARWR250620C000100003510.04.1 - 6.25.35In
 Put
ARWR250620P00035000035.018.2 - 21.615.46In
 Put
ARWR250620P00030000030.013.6 - 16.610.65In
 Put
ARWR250620P00028000028.011.4 - 14.410.3In
 Put
ARWR250620P00027000127.010.3 - 13.37.8In
 Put
ARWR250620P00026000126.010.1 - 12.56.0In
 Put
ARWR250620P000250006925.09.4 - 11.98.35In
 Put
ARWR250620P0002400037024.08.5 - 10.39.09In
 Put
ARWR250620P0002300026823.07.9 - 9.36.55In
 Put
ARWR250620P0002200024422.06.6 - 8.45.4In
 Put
ARWR250620P0002100015721.06.1 - 7.14.4In
 Put
ARWR250620P0002000047120.05.3 - 5.84.93In
 Put
ARWR250620P0001900024119.04.2 - 5.34.4In
 Put
ARWR250620P0001800019418.03.5 - 4.13.3In
 Put
ARWR250620P0001700012817.02.9 - 3.32.86In
 Put
ARWR250620P000160003916.01.8 - 2.62.1In
 Put
ARWR250620P000150007915.01.45 - 2.01.65In
 Put
ARWR250620P0001400011414.01.2 - 1.951.7Out
 Put
ARWR250620P000130003213.00.0 - 2.70.8Out
 Put
ARWR250620P000120001112.00.0 - 1.450.15Out

Arrowhead Pharmaceuticals Market Cap Over Time

   Market Cap   
       Timeline  

Arrowhead Total Stockholder Equity

Total Stockholder Equity

223.92 Million

At this time, Arrowhead Pharmaceuticals' Total Stockholder Equity is relatively stable compared to the past year.

Arrowhead Pharmaceuticals Corporate Management

CPA CPAChief OfficerProfile
Kenneth MyszkowskiChief OfficerProfile
Javier MDChief OfficerProfile
Bruce MDChief ScientistProfile
Vincent CFAHead VPProfile
MBA MDChief MedicineProfile
Tracie OliverChief OfficerProfile

Additional Tools for Arrowhead Stock Analysis

When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.